Giaginis Costas, Theocharis Stamatios, Tsantili-Kakoulidou Anna
University of Athens, Department of Pharmaceutical Chemistry, School of Pharmacy, Panepistimiopolis, Zografou, Athens 157 71, Greece.
Expert Opin Investig Drugs. 2007 Apr;16(4):413-7. doi: 10.1517/13543784.16.4.413.
The fact that PPAR-gamma is expressed dramatically higher in fat, regulating gene transcription in response to small lipophilic ligands, supports an essential role of increased lipophilicity for those ligands. On the other hand, the skepticism concerning high lipophilicity as a characteristic associated with undesirable effects and formulation problems raises the question of how much lipophilicity should be incorporated in the ligand molecules so that they comply with generally accepted guidelines. A survey on the lipophilic behavior of thiazolidinediones and tyrosine-based derivatives with well-established PPAR-gamma affinity and functional activity suggests that excessive lipophilicity may not be favorable for their action.
过氧化物酶体增殖物激活受体γ(PPAR-γ)在脂肪组织中表达显著更高,可响应亲脂性小分子配体调节基因转录,这一事实支持了这些配体亲脂性增加的重要作用。另一方面,对于高亲脂性作为与不良影响和制剂问题相关的特性存在的怀疑,引发了一个问题,即配体分子中应引入多少亲脂性才能符合普遍接受的指导原则。一项关于噻唑烷二酮类和具有明确PPAR-γ亲和力及功能活性的酪氨酸类衍生物亲脂行为的调查表明,过度亲脂性可能对其作用不利。